SAB Biotherapeutics (SABS) Research & Development (2021 - 2025)
Historic Research & Development for SAB Biotherapeutics (SABS) over the last 5 years, with Q3 2025 value amounting to $9.0 million.
- SAB Biotherapeutics' Research & Development rose 1454.86% to $9.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $31.3 million, marking a year-over-year increase of 1542.35%. This contributed to the annual value of $30.3 million for FY2024, which is 8317.69% up from last year.
- As of Q3 2025, SAB Biotherapeutics' Research & Development stood at $9.0 million, which was up 1454.86% from $7.0 million recorded in Q2 2025.
- Over the past 5 years, SAB Biotherapeutics' Research & Development peaked at $18.7 million during Q2 2021, and registered a low of $3.7 million during Q2 2023.
- Its 5-year average for Research & Development is $8.6 million, with a median of $7.7 million in 2025.
- Per our database at Business Quant, SAB Biotherapeutics' Research & Development plummeted by 6595.91% in 2023 and then skyrocketed by 9480.83% in 2024.
- Over the past 5 years, SAB Biotherapeutics' Research & Development (Quarter) stood at $10.6 million in 2021, then tumbled by 32.96% to $7.1 million in 2022, then crashed by 39.8% to $4.3 million in 2023, then surged by 78.05% to $7.7 million in 2024, then increased by 17.23% to $9.0 million in 2025.
- Its last three reported values are $9.0 million in Q3 2025, $7.0 million for Q2 2025, and $7.7 million during Q1 2025.